BioCentury
ARTICLE | Clinical News

AntriaBio preclinical data

July 13, 2015 7:00 AM UTC

AntriaBio said a single subcutaneous dose of 37.5 mg/kg AB101 in rats and a single subcutaneous dose of 10 or 37.5 mg/kg AB101 in dogs led to a maximum insulin concentration (Cmax) of >30 ng/mL at 7-9...